Concentrix (NASDAQ:CNXC) Trading Up 10.9% – What’s Next?

Posted by George Bondi on Aug 19th, 2026

Concentrix Corporation (NASDAQ:CNXC – Get Free Report) shares rose 10.9% during mid-day trading on Wednesday . The stock traded as high as $26.42 and last traded at $26.26. 506,695 shares changed hands during mid-day trading, a decline of 68% from the average session volume of 1,602,882 shares. The stock had previously closed at $23.67.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on CNXC. Weiss Ratings reiterated a “sell (d)” rating on shares of Concentrix in a report on Friday, July 24th. Bank of America reduced their price objective on Concentrix from $32.00 to $26.00 and set a “neutral” rating on the stock in a research report on Tuesday, June 30th. Robert W. Baird lowered their target price on Concentrix from $40.00 to $30.00 and set an “outperform” rating for the company in a report on Tuesday, June 30th. Zacks Research downgraded Concentrix from a “hold” rating to a “strong sell” rating in a report on Thursday, July 2nd. Finally, Barrington Research reduced their price objective on shares of Concentrix from $38.00 to $30.00 and set an “outperform” rating on the stock in a research note on Tuesday, June 30th. Three equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $32.75.

View Our Latest Research Report on CNXC

Concentrix Stock Performance

The company has a debt-to-equity ratio of 1.46, a current ratio of 1.18 and a quick ratio of 1.18. The stock has a market cap of $1.54 billion, a P/E ratio of -1.19, a P/E/G ratio of 0.45 and a beta of 0.45. The company has a fifty day moving average price of $24.46 and a 200 day moving average price of $27.72.

Concentrix (NASDAQ:CNXC – Get Free Report) last released its quarterly earnings results on Monday, June 29th. The company reported $2.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.64 by ($0.01). The company had revenue of $2.46 billion for the quarter, compared to analyst estimates of $2.47 billion. Concentrix had a negative net margin of 13.16% and a positive return on equity of 19.82%. Concentrix’s revenue for the quarter was up 1.9% on a year-over-year basis. During the same quarter last year, the firm posted $2.70 EPS. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. On average, equities analysts expect that Concentrix Corporation will post 9.67 EPS for the current year.

Concentrix Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, August 4th. Investors of record on Friday, July 24th were given a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a dividend yield of 5.7%. The ex-dividend date of this dividend was Friday, July 24th. Concentrix’s dividend payout ratio (DPR) is presently -6.75%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Royal Bank of Canada boosted its stake in Concentrix by 9.5% in the first quarter. Royal Bank of Canada now owns 47,501 shares of the company’s stock valued at $2,643,000 after acquiring an additional 4,133 shares during the last quarter. Goldman Sachs Group Inc. increased its position in shares of Concentrix by 75.1% during the first quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company’s stock valued at $23,552,000 after buying an additional 181,546 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Concentrix by 17.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company’s stock worth $8,152,000 after purchasing an additional 21,746 shares in the last quarter. Focus Partners Wealth purchased a new stake in shares of Concentrix in the first quarter worth $781,000. Finally, Geneos Wealth Management Inc. raised its holdings in shares of Concentrix by 532.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after acquiring an additional 522 shares in the last quarter. Hedge funds and other institutional investors own 90.34% of the company’s stock.

About Concentrix

(Get Free Report)

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.